BioCentury | Oct 20, 1997
Finance

European private rounds

...drugs Molecules to Market £1.7M Principal backers of the Belfast diagnostics company include 3i & Enterprise Equity...
Items per page:
1 - 1 of 1
BioCentury | Oct 20, 1997
Finance

European private rounds

...drugs Molecules to Market £1.7M Principal backers of the Belfast diagnostics company include 3i & Enterprise Equity...
Items per page:
1 - 1 of 1